JPWO2024024760A1 - - Google Patents

Info

Publication number
JPWO2024024760A1
JPWO2024024760A1 JP2024537730A JP2024537730A JPWO2024024760A1 JP WO2024024760 A1 JPWO2024024760 A1 JP WO2024024760A1 JP 2024537730 A JP2024537730 A JP 2024537730A JP 2024537730 A JP2024537730 A JP 2024537730A JP WO2024024760 A1 JPWO2024024760 A1 JP WO2024024760A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024537730A
Other languages
Japanese (ja)
Other versions
JPWO2024024760A5 (https=
JP7782046B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2024024760A1 publication Critical patent/JPWO2024024760A1/ja
Publication of JPWO2024024760A5 publication Critical patent/JPWO2024024760A5/ja
Application granted granted Critical
Publication of JP7782046B2 publication Critical patent/JP7782046B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • C07D231/22One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • C07D231/22One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C07D231/24One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms having sulfone or sulfonic acid radicals in the molecule
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06Heterocyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2024537730A 2022-07-25 2023-07-25 ピラゾロン化合物及びピラゾロン化剤 Active JP7782046B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022118259 2022-07-25
JP2022118259 2022-07-25
PCT/JP2023/027102 WO2024024760A1 (ja) 2022-07-25 2023-07-25 ピラゾロン化合物及びピラゾロン化剤

Publications (3)

Publication Number Publication Date
JPWO2024024760A1 true JPWO2024024760A1 (https=) 2024-02-01
JPWO2024024760A5 JPWO2024024760A5 (https=) 2024-11-12
JP7782046B2 JP7782046B2 (ja) 2025-12-08

Family

ID=89706371

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024537730A Active JP7782046B2 (ja) 2022-07-25 2023-07-25 ピラゾロン化合物及びピラゾロン化剤

Country Status (4)

Country Link
US (1) US20250129030A1 (https=)
EP (1) EP4563572A1 (https=)
JP (1) JP7782046B2 (https=)
WO (1) WO2024024760A1 (https=)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5980470A (ja) * 1982-10-29 1984-05-09 Konishiroku Photo Ind Co Ltd オキソノ−ル染料の製造方法
JPH03289653A (ja) * 1990-04-06 1991-12-19 Konica Corp ハロゲン化銀カラー写真感光材料
JPH0485538A (ja) * 1990-07-28 1992-03-18 Konica Corp ハロゲン化銀カラー写真感光材料
JPH08229302A (ja) * 1995-02-24 1996-09-10 Konica Corp 固体微粒子の製造方法および製造装置
JP2003059547A (ja) * 2001-08-17 2003-02-28 Nippon Kayaku Co Ltd 色素増感光電変換素子
JP2005015750A (ja) * 2003-06-24 2005-01-20 Yamada Chem Co Ltd ペリミジン化合物
WO2006129583A1 (ja) * 2005-05-30 2006-12-07 Genecare Research Institute Co., Ltd. ピラゾロン誘導体
WO2006129587A1 (ja) * 2005-05-30 2006-12-07 Genecare Research Institute Co., Ltd. ピラゾロン誘導体を含有する医薬組成物
JP2009093909A (ja) * 2007-10-09 2009-04-30 Konica Minolta Business Technologies Inc 色素増感光電変換素子及びその製造方法
CN110128345A (zh) * 2019-05-13 2019-08-16 上海大学 一种吡唑酮衍生物的制备方法

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5980470A (ja) * 1982-10-29 1984-05-09 Konishiroku Photo Ind Co Ltd オキソノ−ル染料の製造方法
JPH03289653A (ja) * 1990-04-06 1991-12-19 Konica Corp ハロゲン化銀カラー写真感光材料
JPH0485538A (ja) * 1990-07-28 1992-03-18 Konica Corp ハロゲン化銀カラー写真感光材料
JPH08229302A (ja) * 1995-02-24 1996-09-10 Konica Corp 固体微粒子の製造方法および製造装置
JP2003059547A (ja) * 2001-08-17 2003-02-28 Nippon Kayaku Co Ltd 色素増感光電変換素子
JP2005015750A (ja) * 2003-06-24 2005-01-20 Yamada Chem Co Ltd ペリミジン化合物
WO2006129583A1 (ja) * 2005-05-30 2006-12-07 Genecare Research Institute Co., Ltd. ピラゾロン誘導体
WO2006129587A1 (ja) * 2005-05-30 2006-12-07 Genecare Research Institute Co., Ltd. ピラゾロン誘導体を含有する医薬組成物
JP2009093909A (ja) * 2007-10-09 2009-04-30 Konica Minolta Business Technologies Inc 色素増感光電変換素子及びその製造方法
CN110128345A (zh) * 2019-05-13 2019-08-16 上海大学 一种吡唑酮衍生物的制备方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANGELASTRO, ANTONIO ET AL.: "Galactose Oxidase Enables Modular Assembly of Conjugates from Native Antibodies with High Drug-to- A", CHEMSUSCHEM, vol. 15, e202102592, JPN6023042286, 20 January 2022 (2022-01-20), pages 1 - 4, ISSN: 0005738795 *
JANSON, NILS ET AL.: "Bifunctional Reagents for Formylglycine Conjugation: Pitfalls and Breakthroughs", CHEMBIOCHEM, vol. 21, JPN6023042285, 18 September 2020 (2020-09-18), pages 3580 - 3593, ISSN: 0005738794 *
KUDIRKA, ROMAS A. ET AL.: "Site-Specific Tandem Knoevenagel Condensation-Michael Addition To Generate Antibody-Drug Conjugates", ACS MED. CHEM. LETT., vol. 7, JPN6023042284, 30 August 2016 (2016-08-30), pages 994 - 998, ISSN: 0005738793 *

Also Published As

Publication number Publication date
EP4563572A1 (en) 2025-06-04
WO2024024760A1 (ja) 2024-02-01
US20250129030A1 (en) 2025-04-24
JP7782046B2 (ja) 2025-12-08

Similar Documents

Publication Publication Date Title
JPWO2024024760A1 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023001987A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13163U (https=)
BY13159U (https=)
CN307044685S (https=)
BY13168U (https=)
BY13166U (https=)
BY13165U (https=)
BY13164U (https=)
BY13142U (https=)
BY13141U (https=)
BY13144U (https=)
CN307045268S (https=)
BY13140U (https=)
BY13149U (https=)
BY13162U (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240906

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240906

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250708

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250903

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250912

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20251125

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20251126

R150 Certificate of patent or registration of utility model

Ref document number: 7782046

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150